INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

People assigned to a diet, food or program and measured.

214 studies · page 4 of 9

2012 / Randomized double-blind placebo-controlled clinical trial

Ginger capsules reduced chemotherapy-induced vomiting across anticipatory, acute, and delayed phases in women with breast cancer.

A randomized double-blind placebo-controlled trial evaluated the effect of ginger on chemotherapy-induced vomiting in 80 women with breast cancer. Participants received either 250 mg ginger powder capsules or starch placebo capsules 4 times daily (1 g/day) for 6 days starting 3 days before chemotherapy. Vomiting cases were significantly lower in the ginger group at the anticipatory (P = 0.04), acute (P = 0.04), and delayed (P = 0.003) phases. Heartburn was the only side effect reported, and it was non-significant (P > 0.05).

Yekta ZP, Ebrahimi SM, Hosseini M, et al. Iran J Nurs Midwifery Res, 2012. PMID 23853643

2011 / Ex vivo serum stimulation study following diet and exercise intervention

Serum from men after a low-fat, high-fiber diet and exercise intervention slowed growth and increased apoptosis in LNCaP prostate cancer cells.

Researchers analyzed the mechanisms underlying anticancer effects of serum from men who underwent a low-fat, high-fiber diet and exercise intervention on prostate cancer cell lines. In androgen-dependent LNCaP cells, post-intervention serum slowed growth and increased apoptosis, effects that were eliminated when IGF-I was added back. Post-intervention serum also increased p53 protein content and reduced NFκB activation in LNCaP cells, with similar results seen when blocking the IGF-I receptor in pre-intervention serum. In androgen-independent PC-3 cells, cell growth was reduced, but other factors were unaffected.

Soliman S, Aronson WJ, Barnard RJ Evid Based Complement Alternat Med, 2011. PMID 19376839

2011 / Multicenter, randomized, double-blind, placebo-controlled trial

Daily supplementation with 80 or 120 mg soy hypocotyl isoflavones for 2 years demonstrated minimal health risks in postmenopausal women.

A 24-month trial evaluated the safety and clinical outcomes of daily supplementation with 80 or 120 mg aglycone equivalent soy hypocotyl isoflavones (plus calcium and vitamin D) versus placebo in 403 postmenopausal women. After 2 years, all clinical chemistry values remained within normal ranges, though blood urea nitrogen increased significantly at 2 years (P = 0.048) but not at 1 year (P = 0.343). Isoflavone supplementation did not alter blood lymphocyte or serum free thyroxine concentrations, nor did it cause significant differences in endometrial thickness or fibroids. Two serious adverse events occurred (one breast cancer and one estrogen receptor-negative endometrial cancer), which was below the expected population rate.

Steinberg FM, Murray MJ, Lewis RD, et al. Am J Clin Nutr, 2011. PMID 21177797

2011 / Interventional study

Visiting forest parks increased human natural killer activity, elevated anti-cancer proteins, and lowered stress hormones for over 30 days.

The study evaluated the effects of visiting forest parks compared to a city on immune and stress markers in male and female subjects. Visiting forest parks, but not a city, enhanced natural killer (NK) activity, increased anti-cancer proteins (perforin, granzymes A and B, and granulysin) in NK cells, and reduced stress hormone levels. This enhancement in NK activity lasted for more than 30 days following the trips.

Li Q, Kawada T Int J Immunopathol Pharmacol, 2011. PMID 21329564

2011 / Intervention trial

Curcumin suppressed 8-hydroxy-20-deoxyguanosine levels and induced DNA repair enzymes in people chronically exposed to arsenic.

A study evaluated the role of curcumin in 66 asymptomatic volunteers who were chronically exposed to high arsenic levels in West Bengal, India. Curcumin intervention suppressed levels of 8-hydroxy-20-deoxyguanosine and OGG1 expression, which had been elevated by arsenic. Furthermore, curcumin induced DNA repair enzymes involved in base excision repair and nonhomologous end-joining pathways at both the protein and genetic levels.

Roy M, Sinha D, Mukherjee S, et al. Eur J Cancer Prev, 2011. PMID 21332098

2011 / Randomized controlled trial

Neither aspirin nor resistant starch significantly reduced colorectal polyp counts in young FAP patients.

A multicenter trial randomized 206 young individuals with familial adenomatous polyposis to aspirin (600 mg/day), resistant starch (30 g/day), both, or placebos for 1 to 12 years. Among 133 patients with follow-up endoscopy, neither aspirin (RR = 0.77; 95% CI, 0.54-1.10) nor resistant starch (RR = 1.05; 95% CI, 0.73-1.49) significantly reduced rectal and sigmoid polyp numbers. Aspirin displayed a non-significant trend toward smaller maximum polyp size.

Burn J, Bishop DT, Chapman PD, et al. Cancer Prev Res (Phila), 2011. PMID 21543343

2011 / Crossover intervention study

A single sip of a strong alcoholic beverage produced carcinogenic concentrations of acetaldehyde in the oral cavity for at least 10 minutes.

Eight volunteers tasted 5 ml of 40 vol.% ethanol without acetaldehyde and 40 vol.% calvados containing 2400 μM acetaldehyde, with and without prior ethanol ingestion (0.5 g/kg body weight). Salivary acetaldehyde concentration was significantly higher at 30 seconds after calvados than ethanol alone, both with (215 vs. 128 μmol/l, p<0.05) and without (258 vs. 89 μmol/l, p<0.05) alcohol ingestion. From 2 minutes onwards, salivary acetaldehyde concentrations decreased without significant differences between beverages, but remained above carcinogenic levels at 10 minutes. Systemic alcohol distribution from blood to saliva had no additional effect on salivary acetaldehyde levels.

Linderborg K, Salaspuro M, Väkeväinen S Food Chem Toxicol, 2011. PMID 21641957

2011 / Randomized controlled trial protocol

Trial protocol evaluates green tea extract for preventing recurrent colorectal adenomas.

This protocol describes a randomized multicenter trial designed to assess green tea extract against placebo for preventing metachronous colon adenomas. A planned cohort of 2,534 post-polypectomy patients will receive 150 mg epigallocatechin gallate twice daily or placebo for 3 years. The primary endpoints include the incidence, count, and histology of adenomas identified during follow-up colonoscopy.

Stingl JC, Ettrich T, Muche R, et al. BMC Cancer, 2011. PMID 21851602

2011 / Comparative pharmacokinetic study

Rodents showed substantially higher circulating levels of active unconjugated genistein than humans.

Circulating total and unconjugated isoflavone concentrations were evaluated across 7 studies in humans and rodents. In adults and infants consuming soy foods, genistein, or soy supplements, unconjugated genistein was <1% in steady state and <2% at peak concentrations. In contrast, rodents conjugated isoflavones less efficiently, with unconjugated genistein reaching 4.0 ± 0.6% in Sprague-Dawley rats, and 4.6 ± 0.6%, 11.6 ± 0%, and 30.1 ± 4.3% in C57BL/6, nude, and transgenic AngptL4B6 mice, representing 20 to 150 times that in humans.

Setchell KD, Brown NM, Zhao X, et al. Am J Clin Nutr, 2011. PMID 21955647

2011 / Intervention trial with control group

Flaxseed supplementation increased endostatin levels in normal human breast tissue in vivo without altering VEGF or angiogenin.

Researchers used microdialysis to sample extracellular proteins in normal breast tissue of women before and after six weeks of tamoxifen, six weeks of 25 g/day ground flaxseed, or in control women. Tamoxifen decreased VEGF and angiogenin levels and significantly increased endostatin. Flaxseed did not alter VEGF or angiogenin levels, but like tamoxifen, it significantly increased endostatin levels.

Åberg UW, Saarinen N, Abrahamsson A, et al. PLoS One, 2011. PMID 21984941

2011 / Randomized controlled trial

Dietary supplementation with vitamin E significantly increased the risk of prostate cancer in healthy men.

The SELECT trial randomized 34,887 men to receive selenium (200 μg/d), vitamin E (400 IU/d), both, or placebo to assess prostate cancer risk. Compared to placebo (529 cases), 620 men receiving vitamin E developed prostate cancer (HR 1.17; 99% CI, 1.004-1.36; P = .008), corresponding to an absolute increase of 1.6 cases per 1000 person-years. Prostate cancer cases were 575 in the selenium group (HR 1.09; 99% CI, 0.93-1.27; P = .18) and 555 in the combination group (HR 1.05; 99% CI, 0.89-1.22; P = .46).

Klein EA, Thompson IM, Tangen CM, et al. JAMA, 2011. PMID 21990298

2010 / Randomized controlled trial

Inositol and IP6 improved quality of life in breast cancer patients receiving chemotherapy.

Fourteen patients with invasive ductal breast cancer undergoing polychemotherapy were randomized to receive IP6 plus inositol or placebo. Participants taking the supplement maintained leukocyte and platelet counts without cytopenia, whereas red blood cell counts and tumor markers did not differ between arms. Supplementation resulted in significantly higher functional status (p = 0.0003) and overall quality of life scores (p = 0.05).

Bacić I, Druzijanić N, Karlo R, et al. J Exp Clin Cancer Res, 2010. PMID 20152024

2010 / Randomized crossover and parallel trial

Tomato paste and purified lycopene modified gene expression in prostate cancer cells.

In a trial of 30 healthy men aged 50-70 years, participants consumed yellow or red tomato paste (200 g/day) in a crossover design, followed by 16 mg/day purified lycopene or placebo in a parallel phase. Serum from red tomato paste consumption up-regulated IGFBP-3 and the Bax:Bcl-2 ratio while down-regulating cyclin-D1, p53, and Nrf-2 in prostate cancer cells. Purified lycopene up-regulated IGFBP-3, c-fos, and uPAR compared with placebo.

Talvas J, Caris-Veyrat C, Guy L, et al. Am J Clin Nutr, 2010. PMID 20392890

2010 / Open-label study

Neither Agaricus blazei nor Ganoderma lucidum mushroom supplements showed significant anticancer effects in prostate cancer patients with biochemical failure.

In an open-label study, 51 patients with biochemical failure following radical prostatectomy for non-metastasized prostate cancer took either Senseiro (Agaricus blazei Murill extract, n=32) or Rokkaku Reishi (Ganoderma lucidum, n=15) for 6 months. Forty-seven patients completed the protocol and were assessed. No partial response (a 50% or greater decrease in serum PSA) was observed in any patient. Alteration of PSA doubling time did not correlate with serum testosterone levels, and no serious adverse effects were observed.

Yoshimura K, Kamoto T, Ogawa O, et al. Int J Urol, 2010. PMID 20412340

2010 / Intervention study (pre-post with control weekend)

A day trip to a forest park significantly increased human natural killer activity and anti-cancer proteins in healthy male subjects for at least 7 days.

Twelve healthy male subjects aged 35-53 years took a day trip to a forest park, walking for two hours in the morning and afternoon. Measurements were taken before the trip (control), the following day, and 7 days after the trip. The day trip significantly increased NK activity, numbers of CD16(+) and CD56(+) NK cells, and perforin, granulysin, and granzyme A/B-expressing NK cells, while significantly decreasing CD4(+) T cells, blood cortisol, and urinary adrenaline. The increased NK activity persisted for 7 days after the trip.

Li Q, Kobayashi M, Inagaki H, et al. J Biol Regul Homeost Agents, 2010. PMID 20487629

2010 / Randomized controlled trial

Green tea intake led to detectable tea polyphenols in human prostate tissue.

In a trial of men with localized prostate cancer, consuming six cups of green tea daily (n = 8) for 3 to 6 weeks before radical prostatectomy produced detectable tissue concentrations of EGCG (42.1 +/- 32.4 pmol/g) and 4''-MeEGCG (38.9 +/- 19.5 pmol/g). These polyphenols were absent in tissue from control participants consuming water (n = 9). Most detected catechins in tissue were non-conjugated.

Wang P, Aronson WJ, Huang M, et al. Cancer Prev Res (Phila), 2010. PMID 20628004

2010 / Uncontrolled clinical trial

Breast tissue Ki-67 was lower after secoisolariciresinol diglycoside supplementation in high-risk women.

In a single-arm trial, 45 premenopausal women at high risk for breast cancer received 50 mg daily of secoisolariciresinol diglycoside for 12 months. Ki-67 decreased from a median of 4% to 2% in 36 participants (P < 0.001). Atypical cytology was also less prevalent after treatment (P = 0.035), alongside significant increases in median plasma enterolactone and total lignans.

Fabian CJ, Kimler BF, Zalles CM, et al. Cancer Prev Res (Phila), 2010. PMID 20724470

2010 / Randomized controlled crossover trial

Rye whole grain and bran intake lowered plasma PSA, insulin, and urinary C-peptide compared with refined wheat in men with prostate cancer.

In a randomized controlled crossover study, 17 men diagnosed with prostate cancer consumed 485 g of rye whole grain and bran products (RP) or refined wheat products with added cellulose (WP) (~50% of daily energy intake). Plasma total PSA concentrations were lower after RP compared with WP, showing a mean treatment effect of -14% (P = 0.04). Fasting plasma insulin and 24-h urinary C-peptide excretion were also lower after RP compared with WP (P < 0.01 and P = 0.01, respectively), while daily excretion of 5 lignans was higher (P < 0.001).

Landberg R, Andersson SO, Zhang JX, et al. J Nutr, 2010. PMID 20980650

2009 / Randomized crossover trial

Seaweed and soy supplementation altered estrogen and phytoestrogen metabolism in postmenopausal women.

In a randomized crossover trial, 15 healthy postmenopausal women ingested 5 g daily of seaweed or placebo for 7 weeks, adding soy protein during the final week. Seaweed dosage was inversely correlated with serum estradiol (r = -0.70, P = 0.003). Combined seaweed and soy increased urinary 2-hydroxyestrogen excretion (P = 0.0001), the 2:16 ratio (P = 0.01), and equol excretion by 58% in equol producers (P = 0.0001).

Teas J, Hurley TG, Hebert JR, et al. J Nutr, 2009. PMID 19321575

2009 / Randomized controlled trial

Adding Aloe arborescens to chemotherapy improved tumor regression and 3-year survival in metastatic cancer.

In a randomized trial of 240 patients with metastatic solid tumors, participants received chemotherapy alone or chemotherapy with oral Aloe arborescens (10 ml three times daily). Patients receiving adjuvant Aloe had significantly higher percentages of objective tumor regression and disease control compared to chemotherapy alone. The percentage of patients surviving at 3 years was also significantly higher in the Aloe group.

Lissoni P, Rovelli F, Brivio F, et al. In Vivo, 2009. PMID 19368145

2009 / Interventional pharmacokinetic study

Using alcohol-containing mouthwashes led to transiently elevated salivary acetaldehyde concentrations similar to those seen after alcohol consumption.

Healthy nonsmoking volunteers (n = 4) rinsed with 13 ready-to-use mouthwashes (5-27% vol alcohol) for 30 seconds, and saliva was measured at 0.5, 2, 5, and 10 minutes. Salivary acetaldehyde content was 41 +/- 15 microM at 0.5 min, 52 +/- 14 microM at 2 min, 32 +/- 7 microM at 5 min, and 15 +/- 7 microM at 10 min, significantly above endogenous levels. Twice-daily use produced an average systemic exposure of 0.26 microg/kg bodyweight/day (margin of exposure 217,604), but local salivary concentrations reached levels linked with DNA adduct formation and sister chromatid exchange in vitro.

Lachenmeier DW, Gumbel-Mako S, Sohnius EM, et al. Int J Cancer, 2009. PMID 19444911

2009 / Prospective, controlled intervention trial

Bariatric surgery was associated with reduced cancer incidence in obese women, but not in obese men, over a median 10.9-year follow-up.

The Swedish Obese Subjects study followed 2,010 obese patients undergoing bariatric surgery and 2,037 matched controls receiving conventional treatment for a median of 10.9 years. Surgery resulted in a sustained mean weight reduction of 19.9 kg over 10 years compared to a 1.3 kg gain in controls. First-time cancers were significantly lower in the surgery group (117 cases) compared to controls (169 cases; HR 0.67, 95% CI 0.53-0.85, p=0.0009). The reduction was observed in women (HR 0.58, 95% CI 0.44-0.77, p=0.0001), but not in men (HR 0.97, 95% CI 0.62-1.52, p=0.90; sex-treatment interaction p=0.054).

Sjöström L, Gummesson A, Sjöström CD, et al. Lancet Oncol, 2009. PMID 19556163

2009 / Controlled rodent feeding experiment and human pilot validation study

Hair PhIP was detected in meat-eaters, and rodent fur accumulation reflected dietary HAA dose.

Researchers developed a method to quantify heterocyclic aromatic amines (HAAs) in human hair and rodent fur. In a pilot study of 12 human volunteers, PhIP was detected in 6 meat-eaters (290 to 890 pg/g hair) and 1 vegetarian (65 pg/g hair), while MeIQx and AalphaC were below the quantification limit (50 pg/g hair). Hair PhIP levels from 2 meat-eaters varied by less than 24% over 6 months. In female C57BL/6 mice given HAAs in drinking water for 1 month (0 and 0.080 to 800 microg/kg body weight), fur HAA levels and liver and colon DNA adducts were positively related to dose (p < 0.0001), though fur HAA levels did not correlate with adducts after adjusting for dose.

Bessette EE, Yasa I, Dunbar D, et al. Chem Res Toxicol, 2009. PMID 19588936

2009 / Intervention trial

Oral curcumin reduced paraprotein load in half of patients with baseline paraprotein levels over 20 g/L and decreased a bone turnover marker in 27% of patients.

Twenty-six patients with monoclonal gammopathy of undefined significance (MGUS) were administered 4 grams/day of oral curcumin to examine its effects on plasma cells and osteoclasts. Among patients with a paraprotein level >20 g/L, 50% (5 of 10) experienced a 12% to 30% reduction in paraprotein levels during curcumin therapy. Additionally, 27% of patients on curcumin demonstrated a >25% decrease in the bone turnover marker urinary N-telopeptide of type I collagen.

Golombick T, Diamond TH, Badmaev V, et al. Clin Cancer Res, 2009. PMID 19737963